Join to view full profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-7873
Dr. Richard is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shambavi Richard is an oncologist based in New York, NY, specializing in myeloproliferative disorders, bone marrow failure syndromes, aplastic anemia, multiple myeloma, and myelodysplastic syndromes. She completed her fellowship in Hematology and Medical Oncology at Montefiore Medical Center/Albert Einstein College of Medicine and her residency in Internal Medicine at BronxCare Health System. Dr. Richard is an author of several publications, including articles in "Blood Advances" and "Nature Cancer," focusing on multiple myeloma and related therapies. Her work has been cited by other publications, indicating her contributions to the field of oncology.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1997 - 1998
BronxCare Health SystemResidency, Internal Medicine, 1992 - 1995
Stanley Medical College SMCClass of 1988
Certifications & Licensure
NY State Medical License 1995 - 2026
NJ State Medical License 2004 - 2021
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification DigiDMS, DigiDMS, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification DigiDMS, DigiDMS, Inc., 2014, 2016-2017
Publications & Presentations
PubMed
- Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.Tarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, Christian Salib, Shafinaz Hussein
Haematologica. 2026-07-02 - Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.Mahmoud R Gaballa, Kelley Julian, Aimaz Afrough, Doris K Hansen, Utkarsh Goel
Blood Advances. 2026-07-02 - Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference.Ajai Chari, Caitlin Costello, Amrita Krishnan, Krina Patel, Rahul Banerjee
American Journal of Hematology. 2026-07-01
Press Mentions
CAR-T Destined for Earlier Lines of Therapy in Blood Cancers, Experts SayNovember 18th, 2022
Professional Memberships
- Member
- International Myeloma SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
